250
Participants
Start Date
July 2, 2018
Primary Completion Date
January 30, 2026
Study Completion Date
April 27, 2026
Stents
"US-guided puncture of vein, fluoroscopic monitoring of catheter/guidewire manipulations, baseline venogram of CFV through infrarenal IVC.~Iliac vein should be pre-dilated to at least 12 mm. Bare, self-expanding stents made of elgiloy or nitinol legally marketed in the US for any indication and that are at least 12 mm in diameter should be used to recanalize the entire diseased segment of vein.~The use of devices \> 14 mm is highly recommended for the iliac vein and dilated to at least 14 mm, unless compelling patient factors dictates dilatation to a smaller diameter.~Balloon angioplasty of inflow veins.~After successful iliac vein recanalization, patients who continue to be symptomatic beyond 2 weeks follow-up and who have valvular reflux in GSV, accessory GSV, anterolateral thigh circumflex, and/or SSV should be offered endovenous ablation.~Any FDA-approved method may be used including radiofrequency or laser ablation, sclerotherapy or pharmacomechanical ablation."
New York University Medical Center, New York
New York Presbyterian-Weill Cornell Medicine, NewYork
Staten Island Hospital, Staten Island
Stony Brook Hospital, Stony Brook
University of Vermont Health Network - CVPH, Plattsburgh
University of Pittsburg, Pittsburgh
Thomas Jefferson University Hospital, Philadelphia
Temple University, Philadelphia
Christiana Care Hospital, Newark
University of Maryland, Baltimore
University of Virginia, Charlottesville
University of North Carolina, Chapel Hill
University of Mississippi Medical Center, Jackson
Jobst Vascular Institute, Toledo
University Hospitals Cleveland Medical Center, Cleveland
Indiana University, Indianapolis
University of Iowa, Iowa City
Medical College of Wisconsin, Milwaukee
Gundersen Health System, La Crosse
NorthShore University Health System, Evanston
Northwestern University, Evanston
Rush Medical Center, Chicago
University of Chicago, Chicago
Washington University School of Medicine, St Louis
St. Elizabeth's Hospital, Lincoln
University of Oklahoma, Oklahoma City
University of Texas Health Science Center at Houston, Houston
St. Joseph's Vascular Institute, Orange
UCSF, San Francisco
Oregon Health & Sciences University, Portland
Yale New Haven Hospital, New Haven
Ontario Clinical Oncology Group (OCOG)
OTHER
Massachusetts General Hospital
OTHER
Saint Luke's Mid America Heart Institute
UNKNOWN
Washington University School of Medicine
OTHER